Interphotoreceptor Retinoid Binding Protein Fragment (IRBP), a 20-residue peptide and a major pathogenic epitope, is present in the first homologous repeat of the interphotoreceptor retinoid binding protein peptide (IRBP 161–180), which can induce posterior uveitis (EAU).
Interphotoreceptor Retinoid Binding Protein Fragment IRBP is a specialized peptide fragment derived from the larger interphotoreceptor retinoid-binding protein, a key glycoprotein involved in the visual cycle within the vertebrate retina. As a segment of this essential protein, the IRBP fragment retains distinct biochemical features relevant to retinoid transport and photoreceptor cell biology. Its structure and functional motifs make it an important research tool for probing the molecular mechanisms underlying visual signal transduction, retinoid trafficking, and protein-protein interactions within the retinal environment. The fragment is widely used in experimental systems to dissect the specific domains responsible for ligand binding and to model aspects of retinal physiology in vitro.
Protein interaction studies: The IRBP fragment serves as a valuable probe for elucidating the molecular interactions between retinoid-binding proteins and their ligands. By isolating functional domains, researchers can investigate the specific amino acid residues involved in retinoid recognition and binding, enabling a deeper understanding of the structural determinants that govern these critical interactions. Such studies are instrumental in mapping binding sites, characterizing affinity profiles, and defining the conformational changes that occur upon ligand association.
Retinoid transport mechanism research: Utilization of the IRBP fragment provides a controlled system for examining the mechanistic aspects of retinoid shuttling between photoreceptors and the retinal pigment epithelium. Scientists employ this fragment to model the transfer of vitamin A derivatives and to assess the efficiency and specificity of retinoid movement in the interphotoreceptor matrix. Insights gained from these experiments contribute to the broader comprehension of visual cycle dynamics and the maintenance of photoreceptor health.
Antigenicity and immunological studies: The peptide fragment is frequently used as an immunogen or as a target antigen in immunological assays to investigate autoimmune responses associated with retinal degenerative conditions. By presenting defined epitopes, the IRBP fragment enables the development and validation of antibodies specific to retinal proteins, facilitating studies of immune privilege, autoantibody generation, and the molecular basis of experimental autoimmune uveoretinitis in animal models.
Peptide structure-function analysis: The defined sequence of the IRBP fragment allows researchers to perform detailed structure-function analyses, including mutagenesis, conformational studies, and biophysical characterization. Such work is essential for delineating the roles of specific domains in protein folding, stability, and ligand interaction, and provides foundational data for rational design of synthetic analogs or inhibitors targeting retinoid-binding proteins.
Analytical and assay development: The IRBP fragment is also employed in the development of sensitive biochemical assays aimed at detecting retinoid-binding activity or quantifying retinoid concentrations in complex biological samples. Its well-characterized binding properties make it a suitable standard or calibrator in ligand-binding assays, enzyme-linked immunosorbent assays (ELISAs), and other analytical platforms used in vision research and retinal biochemistry. These applications support high-throughput screening, biomarker discovery, and the standardization of experimental protocols in the field.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More